Skip to main content
Premium Trial:

Request an Annual Quote

Boehringer Ingelheim to Use Genomatix Software

NEW YORK (GenomeWeb News) – Genomatix said today that Boehringer Ingelheim has installed one of its Mining Stations (GMS) and one of its Genome Analyzers (GGA) at its Pharma Research Center in Biberach, Germany.

The company said the two systems combine hardware, databases, and software for next-generation sequencing studies.

The GMS provides mapping of sequencing of any length, "with no practical limits on the number of point mutations, insertions, or deletions," and it can be used for SNP detection and genotyping, copy number analysis, and small RNA analysis. The package includes a GenomeThesaurus for splice junction analysis and identifying new transcriptional units.

The GGA is used to perform a number of deep biological analysis functions on data coming from the GMS, and it annotates genomic coordinates and surrounding areas derived using the GMS or other mapping procedures.

Financial terms of the agreement were not released.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.